Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Purcell

Showing results (201-210 of 226) with videos related to

Pageof 23
Sort By:
Nature|August 31, 2021
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodiesFlorian A Lempp, Leah B Soriaga, Martin Montiel-Ruiz, et al.
Clinical & Translational Immunology|January 28, 2025
Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccinationNicole L Messina, Susie Germano, Amy W Chung, et al.
Science Advances|February 26, 2025
Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variantL Carissa Aurelia, Ruth A Purcell, Robert M Theisen, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Journal of Hepatology|July 17, 2023
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Science (New York, N.Y.)|July 20, 2022
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodiesJun Siong Low, Josipa Jerak, M Alejandra Tortorici, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
Nature Communications|June 5, 2026
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidityMorgan J Skinner, Lukasz Kedzierski, Ruth A Purcell, et al.
Cell Host & Microbe|December 10, 2008
The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasitesMin Yu, T R Santha Kumar, Louis J Nkrumah, et al.
Nature|July 5, 2023
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicryCorey Momont, Ha V Dang, Fabrizia Zatta, et al.
Pageof 23

Showing results (201-210 of 226) with videos related to

Sort By:
Pageof 23
Nature|August 31, 2021
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodiesFlorian A Lempp, Leah B Soriaga, Martin Montiel-Ruiz, et al.
Clinical & Translational Immunology|January 28, 2025
Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccinationNicole L Messina, Susie Germano, Amy W Chung, et al.
Science Advances|February 26, 2025
Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variantL Carissa Aurelia, Ruth A Purcell, Robert M Theisen, et al.
Nature Communications|July 2, 2022
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsJames Brett Case, Samantha Mackin, John M Errico, et al.
Journal of Hepatology|July 17, 2023
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Science (New York, N.Y.)|July 20, 2022
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodiesJun Siong Low, Josipa Jerak, M Alejandra Tortorici, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
Nature Communications|June 5, 2026
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidityMorgan J Skinner, Lukasz Kedzierski, Ruth A Purcell, et al.
Cell Host & Microbe|December 10, 2008
The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasitesMin Yu, T R Santha Kumar, Louis J Nkrumah, et al.
Nature|July 5, 2023
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicryCorey Momont, Ha V Dang, Fabrizia Zatta, et al.
Pageof 23